Cortendo AB Report issue

For profit Phase 1 Phase 3
Founded: Partille Sweden (2015)
Status: Acquired by Strongbridge Biopharma (2015) → now Xeris Pharmaceuticals (2021)

Organization Overview

First Clinical Trial
2015
NCT01838551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cortendo AB